Covid-19 rapid antigen tests rapidly taking off [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Rapid Covid-19 antigen tests test for viral protein, rather than viral genomic DNA which the traditional polymerase chain reaction (PCR) based Covid-19 tests detect. The technology of antigen tests allows them to be easily packaged and easily used in a similar way to a home pregnancy test, which uses the patient sample to give a colourimetric result on a dipstick. Serial Covid-19 testing performed for essential workers who are at high risk, such as teachers, is difficult to perform using PCR technology where the individual has to go to a testing site, can cost $100, and can take between two to three days to receive a test result. There is a clear benefit of rapid antigen tests, which can be performed on-site with results delivered in a matter of minutes. Abbott is positioned to be the leading manufacturer of Covid-19 rapid antigen tests. Abbott reported first-quarter growth of 35.3% year-over-year, driven by significant growth in Rapid Diagnostics, which grew by 302.8% year-over-
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.MarketBeat
- Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market? [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $131.00 price target on the stock.MarketBeat
- Jim Cramer on Microsoft Corporation (MSFT): ‘You've Hit On One Of The Top Five Stocks In This Entire Market' [Yahoo! Finance]Yahoo! Finance
- Jim Cramer on ARM Holdings plc (ARMH): ‘Can It Keep Running?' [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website